NeoGenomics
NEO
#6275
Rank
$0.80 B
Marketcap
$6.24
Share price
-7.14%
Change (1 day)
-57.00%
Change (1 year)

Revenue for NeoGenomics (NEO)

Revenue in 2025 (TTM): $0.67 Billion USD

According to NeoGenomics 's latest financial reports the company's current revenue (TTM ) is $0.67 Billion USD. In 2024 the company made a revenue of $0.66 Billion USD an increase over the revenue in the year 2023 that were of $0.59 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for NeoGenomics from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $0.67 B1.79%
2024 $0.66 B11.65%
2023 $0.59 B16.07%
2022 $0.50 B5.24%
2021 $0.48 B8.97%
2020 $0.44 B8.71%
2019 $0.40 B47.73%
2018 $0.27 B12.21%
2017 $0.24 B1.04%
2016 $0.24 B144.57%
2015 $99.8 M14.62%
2014 $87.06 M30.99%
2013 $66.46 M11.02%
2012 $59.86 M37.68%
2011 $43.48 M26.51%
2010 $34.37 M16.63%
2009 $29.46 M47.23%
2008 $20.01 M73.97%
2007 $11.5 M77.65%
2006 $6.47 M243.5%
2005 $1.88 M237.83%
2004 $0.55 M50.84%
2003 $0.36 M
2000 $0.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
RadNet
RDNT
$1.86 B 178.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
$19.68 M-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
$10.15 B 1,410.80%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
$13.17 B 1,859.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
$27.47 M-95.91%๐Ÿ‡บ๐Ÿ‡ธ USA